WO2023149512A1 - Préparation enzymatique - Google Patents
Préparation enzymatique Download PDFInfo
- Publication number
- WO2023149512A1 WO2023149512A1 PCT/JP2023/003428 JP2023003428W WO2023149512A1 WO 2023149512 A1 WO2023149512 A1 WO 2023149512A1 JP 2023003428 W JP2023003428 W JP 2023003428W WO 2023149512 A1 WO2023149512 A1 WO 2023149512A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein
- component
- enzyme preparation
- deamidase
- enzyme
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims description 82
- 108090000790 Enzymes Proteins 0.000 title claims description 82
- 238000002360 preparation method Methods 0.000 title claims description 52
- 101001122938 Homo sapiens Lysosomal protective protein Proteins 0.000 claims abstract description 52
- 102100028524 Lysosomal protective protein Human genes 0.000 claims abstract description 52
- 229920000768 polyamine Polymers 0.000 claims abstract description 25
- -1 guanidinium compound Chemical class 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 44
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 235000018102 proteins Nutrition 0.000 claims description 43
- 238000004519 manufacturing process Methods 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 22
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical group NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims description 18
- 238000011188 deamidation reaction Methods 0.000 claims description 16
- 239000004475 Arginine Substances 0.000 claims description 14
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- 102000009127 Glutaminase Human genes 0.000 claims description 9
- 108010073324 Glutaminase Proteins 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 229940063673 spermidine Drugs 0.000 claims description 9
- ULEBESPCVWBNIF-BYPYZUCNSA-N L-arginine amide Chemical compound NC(=O)[C@@H](N)CCCNC(N)=N ULEBESPCVWBNIF-BYPYZUCNSA-N 0.000 claims description 8
- 108010082495 Dietary Plant Proteins Proteins 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 235000021120 animal protein Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000006240 deamidation Effects 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 3
- 108091005598 amidated proteins Proteins 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 description 70
- 239000000243 solution Substances 0.000 description 24
- 230000000694 effects Effects 0.000 description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 16
- 238000002835 absorbance Methods 0.000 description 13
- 229910021529 ammonia Inorganic materials 0.000 description 8
- 108091006028 deamidated proteins Proteins 0.000 description 8
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- RPSHOHKFHRFBAZ-UHFFFAOYSA-N n'-[4-(4-aminobutylamino)butyl]butane-1,4-diamine Chemical compound NCCCCNCCCCNCCCCN RPSHOHKFHRFBAZ-UHFFFAOYSA-N 0.000 description 4
- UODZHRGDSPLRMD-UHFFFAOYSA-N sym-homospermidine Chemical compound NCCCCNCCCCN UODZHRGDSPLRMD-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- SOUXAAOTONMPRY-UHFFFAOYSA-N 2-[[5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)C(CCC(=O)N)NC(=O)OCC1=CC=CC=C1 SOUXAAOTONMPRY-UHFFFAOYSA-N 0.000 description 3
- 241000611330 Chryseobacterium Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 235000019419 proteases Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WLHDGVSIMKQJQP-UHFFFAOYSA-N 1,17-Diamino-4,9,13-triazaheptadecane Chemical compound NCCCCNCCCNCCCCNCCCN WLHDGVSIMKQJQP-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RZOHQCYUTFAJLA-UHFFFAOYSA-N Canavalmine Chemical compound NCCCCNCCCNCCCCN RZOHQCYUTFAJLA-UHFFFAOYSA-N 0.000 description 2
- 241000249126 Chryseobacterium proteolyticum Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 241000611354 Empedobacter Species 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 241001467578 Microbacterium Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- QZBYOYPROVGOGE-UHFFFAOYSA-N aminopropylcadaverine Chemical compound NCCCCCNCCCN QZBYOYPROVGOGE-UHFFFAOYSA-N 0.000 description 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960004926 chlorobutanol Drugs 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 235000019833 protease Nutrition 0.000 description 2
- 230000009145 protein modification Effects 0.000 description 2
- 230000020978 protein processing Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- ZAXCZCOUDLENMH-UHFFFAOYSA-N thermospermine Natural products NCCCNCCCNCCCN ZAXCZCOUDLENMH-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SOUXAAOTONMPRY-NSHDSACASA-N 2-[[(2s)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)OCC1=CC=CC=C1 SOUXAAOTONMPRY-NSHDSACASA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 241001467490 Agromyces Species 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- ITSJFETYKWFREV-UHFFFAOYSA-N Aminobutyl canavalmine Natural products NCCCCNCCCCNCCCNCCCCN ITSJFETYKWFREV-UHFFFAOYSA-N 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 102000015790 Asparaginase Human genes 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000145066 Leifsonia Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 241001594505 Luteimicrobium Species 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 241001291960 Myroides Species 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241001136275 Sphingobacterium Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108060008539 Transglutaminase Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- GVBNSPFBYXGREE-CXWAGAITSA-N Visnadin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2[C@@H](OC(C)=O)[C@@H](OC(=O)[C@H](C)CC)C(C)(C)O1 GVBNSPFBYXGREE-CXWAGAITSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- BELZJFWUNQWBES-UHFFFAOYSA-N caldopentamine Chemical compound NCCCNCCCNCCCNCCCN BELZJFWUNQWBES-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000006329 citrullination Effects 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000014156 coffee whiteners Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- GKQPCPXONLDCMU-UHFFFAOYSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1C=CC(=O)OC(C)(C)C GKQPCPXONLDCMU-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- FPTWYQKWFMIJPT-UHFFFAOYSA-N n'-[3-[3-(3-aminopropylamino)propylamino]propyl]butane-1,4-diamine Chemical compound NCCCCNCCCNCCCNCCCN FPTWYQKWFMIJPT-UHFFFAOYSA-N 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108060006632 protein arginine deiminase Proteins 0.000 description 1
- 102000001235 protein arginine deiminase Human genes 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- DODDBCGMRAFLEB-UHFFFAOYSA-N thermospermine Chemical compound NCCCCNCCCNCCCN DODDBCGMRAFLEB-UHFFFAOYSA-N 0.000 description 1
- 102000003601 transglutaminase Human genes 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
Definitions
- the present invention relates to an enzyme preparation of protein deamidase with excellent thermostability.
- Protein deamidase is used as a food additive enzyme, and utilizes the action of converting glutamine residues in food proteins into glutamic acid residues to improve the solubility, emulsification properties, Improves physical functions such as foam properties and gelation properties. Therefore, protein deamidase is expected to be used in various applications including foods and beverages (Patent Document 1). In particular, with the recent rise in health consciousness, the consumption of plant proteins is accelerating, and protein deamidase has a high potential value in plant protein processing applications. On the other hand, protein deamidase has a problem of poor thermostability (Non-Patent Document 1).
- an object of the present invention is to provide an enzyme preparation of protein deamidase with improved thermostability.
- Section 1 An enzyme preparation comprising (A) a protein deamidase and (B) a guanidinium compound and/or a polyamine.
- Section 2. Item 2. The enzyme preparation according to Item 1, wherein the guanidinium compound is arginine and/or argininamide.
- Item 3. Item 3. The enzyme preparation according to Item 1 or 2, wherein the polyamine is spermidine.
- Section 4. Item 4. The enzyme preparation according to any one of Items 1 to 3, wherein the content of the component (B) per 1 U of the component (A) is 0.5 ⁇ mol or more.
- Item 5. Item 5.
- Item 6. The enzyme preparation according to any one of Items 1 to 5, wherein the protein deamidase is protein glutaminase.
- Item 7. Item 7. The enzyme preparation according to any one of Items 1 to 6, which is a liquid preparation.
- Item 8. (P) A method for deamidating a protein, comprising the step of treating a protein with (A) a protein deamidating enzyme in the presence of (B) a guanidium compound and/or a polyamine to allow the deamidation reaction to proceed.
- Item 10. Item 10. The production method according to Item 9, wherein the reaction mixture is prepared by mixing the (P) component with an enzyme preparation containing the (A) component and the (B) component.
- Item 11. Item 10. The production method according to Item 9, wherein the reaction mixture is prepared by mixing a mixture containing the component (P) and the component (B) with the component (A).
- Item 12. Item 12. The production method according to any one of items 9 to 11, wherein the deamidation reaction is carried out at a temperature higher than the optimum temperature of the component (A).
- Item 13 The production method according to any one of items 9 to 12, wherein the component (P) is vegetable protein and/or animal protein.
- Item 14 Deamidation reaction of the component (P) in a reaction mixture containing (P) a protein-containing raw material for food or drink or a pharmaceutical raw material, (A) a protein deamidase, and (B) a guanidium compound and/or a polyamine.
- thermostability an enzyme preparation of protein deamidase with improved thermostability, a protein deamidation method in which the thermostability of protein deamidase is high, and deamidated protein preparation using the same A manufacturing method is provided.
- the enzyme preparation of the present invention comprises (A) a protein deamidase (hereinafter also referred to as “(A) component”) and (B) a guanidium compound and/or polyamine (hereinafter referred to as “(B) component ”) is included.
- A protein deamidase
- B a guanidium compound and/or polyamine
- Protein deamidase The enzyme preparation of the present invention contains protein deamidase as component (A).
- Protein deamidase is an enzyme that deamidates the amide groups of glutamine and asparagine residues in proteins without breaking peptide bonds and cross-linking the protein.
- the protein deamidase used in the enzyme preparation of the present invention includes the following. (1) Enzymes that deamidate glutamine residues in proteins and convert them to glutamic acid (eg, protein glutaminase). (2) Enzymes that deamidate asparagine residues in proteins and convert them to aspartic acid (eg protein asparaginase). (3) Enzymes that deiminate arginine residues in proteins and convert them to citrulline (eg, arginine deiminase, protein arginine deiminase, peptidyl arginine deiminase).
- the deamidated protein has amphipathic properties and becomes an ideal surfactant, and greatly improves the protein's emulsifying power, emulsion stability, foamability and foam stability.
- deamidation of proteins brings about improvements in various functional properties of proteins, and the uses of the proteins increase dramatically.
- Deimination of arginine residues in a protein also increases the hydrophobicity of the protein and changes the higher-order structure of the protein.
- protein deamidase More specific examples of protein deamidase include Chryseobacterium genus, Flavobacterium genus, Empedobacter ( Empedobacter genus, Sphingobacterium genus, Aureobacterium genus, or Myroides genus protein deamidase, Luteimicrobium genus disclosed in WO2015/133590, Protein deamidase from the genera Agromyces, Microbacterium, or Leifsonia.
- Empedobacter Empedobacter genus, Sphingobacterium genus, Aureobacterium genus, or Myroides genus protein deamidase
- Luteimicrobium genus disclosed in WO2015/133590
- Protein deamidase from the genera Agromyces, Microbacterium, or Leifsonia As the component (A) in the enzyme preparation of the present invention, one of these protein deamidase enzymes may be used alone, or two or more of them may be used in combination.
- protein deamidase enzymes derived from the genus Chryseobacterium, more preferably Chryseobacterium genus are preferred from the viewpoint of further enhancing the effect of improving thermal stability by coexistence with component (B).
- Protein glutaminase from the genus more preferably protein glutaminase from the species Chryseobacterium proteolyticum.
- the protein deamidase can be prepared from the culture solution of the microorganism from which the above protein deamidase is derived.
- a specific preparation method includes a method of recovering the protein deamidase from the culture solution or cells of the above microorganisms.
- the enzyme can be separated and/or purified after previously collecting the cells from the culture solution by filtration, centrifugation, or the like, if necessary.
- the cells were collected from the culture solution in advance, and then crushed by pressure treatment, ultrasonic treatment, or the like to expose the enzyme.
- the enzyme can then be isolated and/or purified.
- known protein separation and/or purification methods can be used without particular limitation.
- Various chromatographic methods using The separated and/or purified enzyme can be pulverized by a drying method such as freeze drying or vacuum drying.
- the protein deamidase can be used in the form of an enzymatic agent formulated by pulverizing using a suitable excipient and/or drying aid in the drying method described above.
- the protein deamidase can also be used in the form of an enzymatic agent formulated as a liquid product by adding an appropriate additive to the separated and/or purified enzyme and sterilizing it by filtration.
- the content of component (A) in the enzyme preparation of the present invention is not particularly limited, and may be appropriately set to the extent that the enzymatic activity of component (A) can be utilized when the enzyme preparation of the present invention is used.
- the deamidase activity is, for example, 1 U/mL or higher, preferably 10 U/mL or higher, more preferably 25 U/mL or higher, even more preferably 50 U/mL or higher, particularly preferably 90 U/mL or higher.
- the upper limit of the content of component (A) is, for example, 10,000 U/mL or less, preferably 1,000 U/mL or less, more preferably 500 U/mL or less, even more preferably 200 U/mL or less, particularly preferably 110 U/mL or less. mL or less.
- 1 unit (1 U) is defined as the amount of enzyme that liberates 1 ⁇ mol of ammonia per minute using benzyloxycarbonyl-L-glutaminylglycine (Z-Gln-Gly) as a substrate. .
- the enzyme preparation of the present invention contains a guanidinium compound and/or polyamine as component (B).
- Component (B) improves the thermal stability of component (A).
- guanidinium compounds for use in the present invention include guanidine, arginine, and argininamide. One of these guanidinium compounds may be used alone, or two or more of them may be used in combination. Among these guanidinium compounds, arginine and argininamide are preferred, and argininamide is more preferred, from the viewpoint of further enhancing the effect of improving the thermal stability of component (A).
- the polyamine is not particularly limited as long as it is a linear aliphatic hydrocarbon having two or more amino groups. From the viewpoint of further enhancing the thermal stability improvement effect of component (A), polyamine is preferably used as component (B).
- polyamines used in the present invention include diamines, triamines, tetraamines, pentamines, hexaamines, more specifically putrescine, cadaverine, ethylenediamine, trimethylenediamine, hexamethylenediamine, spermidine, cardine, homospermidine.
- One of these polyamines may be used alone, or two or more of them may be used in combination.
- component (A) includes spermidine.
- the content ratio of the (A) component and the (B) component in the enzyme preparation of the present invention may be appropriately set according to the desired degree of thermal stability improvement effect of the (A) component.
- the content of component (B) per 1U of component (A) is, for example, 0.5 ⁇ mol or more, and from the viewpoint of further enhancing the thermal stability improvement effect of component (A), preferably 0.8 ⁇ mol or more, More preferably 4 ⁇ mol or more, and still more preferably 9 ⁇ mol or more.
- the upper limit of the content of component (B) per 1 U of component (A) is not particularly limited, but is, for example, 50 ⁇ mol or less, preferably 30 ⁇ mol or less, more preferably 15 ⁇ mol or less.
- the specific content of the component (B) in the enzyme preparation of the present invention is determined according to the content of the component (A) and the above ratio. From the viewpoint of further enhancing the effect of improving thermal stability, it is preferably 0.08 M or more, more preferably 0.4 M or more, and still more preferably 0.9 M or more.
- the upper limit of the content of component (B) in the enzyme preparation of the present invention is not particularly limited, it is, for example, 5M or less, preferably 3M or less, and more preferably 1.5M or less.
- the enzyme preparation of the present invention may contain other enzymes, additives, solvents, and/or culture residue components as components other than the above components (A) and (B). and may or may not contain
- enzymes include, for example, amylase ( ⁇ -amylase, ⁇ -amylase, glucoamylase), glucosidase ( ⁇ -glucosidase, ⁇ -glucosidase), galactosidase ( ⁇ -galactosidase, ⁇ -galactosidase), protease (acid protease, medium protease, alkaline protease), peptidase (leucine peptidase, aminopeptidase), lipase, esterase, cellulase, phosphatase (acid phosphatase, alkaline phosphatase), nuclease, deaminase, oxidase, dehydrogenase, glutaminase other than protein glutaminase, pectinase, catalase, dexamethasone stranase, transglutaminase, pullulanase and the
- Additives include excipients, buffers, suspending agents, stabilizers, preservatives, preservatives, pH adjusters, and the like.
- Excipients include starch, dextrin, maltose, trehalose, lactose, D-glucose, sorbitol, D-mannitol, sucrose, glycerol and the like.
- Buffers include phosphate, citrate, acetate and the like.
- Stabilizers include propylene glycol, ascorbic acid and the like.
- Preservatives include phenol, benzalkonium chloride, benzyl alcohol, chlorobutanol, methylparaben and the like.
- antiseptics examples include ethanol, benzalkonium chloride, paraoxybenzoic acid, chlorobutanol and the like. These additives may be contained singly or in combination of multiple types. Solvents include water. The contents of these additives and solvent may be appropriately set according to the types of these components and/or the properties of the enzyme preparation.
- the culture residue components include components contained in the medium used for culturing the component (A) or other enzyme-producing bacteria that are optionally blended, contaminant proteins and bacterial cell components produced by the culture, and the like. mentioned. These culture residue components may be contained singly or in combination of multiple types.
- the properties of the enzyme preparation of the present invention are not particularly limited, and examples thereof include liquid and solid forms (powder, granules, etc.). Since the enzyme preparation of the present invention is excellent in the effect of improving the thermal stability of the component (A), it is possible to effectively obtain the effect of improving the thermal stability even in a liquid form, which is inherently unstable. can. From such a point of view, a preferred example of the properties of the enzyme preparation of the present invention is liquid (liquid preparation).
- the pH (25°C) of the liquid preparation is, for example, 6.5 to 7.5, preferably 6.8 to 7.2, more preferably 6.9 to 7. .1 can be mentioned.
- the enzyme preparation of the present invention can be used for any use that utilizes protein deamidase activity. That is, the enzyme preparation of the present invention suppresses changes in protein properties caused by deamidation of ⁇ -amide groups and/or ⁇ -amide groups of protein glutamine residues and/or asparagine residues to form carboxyl groups. It can be used for any protein modification application of your choice. Specific examples of protein modification include enhancement of protein solubility, enhancement of water dispersibility, enhancement of emulsifying power, enhancement of emulsion stability, and the like.
- Preferred uses of the enzyme preparation of the present invention include uses in the food and pharmaceutical fields, and more preferred uses include uses in the food field. Specifically, it is used to improve the solubility, dispersibility, and emulsifiability of animal proteins and/or vegetable proteins under weakly acidic conditions, which is the pH range of normal foods (e.g., coffee whiteners, juices, etc.). production of acidic beverages, dressings, mayonnaise, and cream); increase in solubility and dispersibility of poorly soluble vegetable proteins (for example, production of tempura flour using wheat gluten); Modification applications (e.g. for producing crackers, biscuits, cookies, pizza or pie crusts); applications for removing or reducing allergens in allergenic proteins in foods (e.g.
- use to reduce the mineral sensitivity of proteins increase the content of soluble minerals in liquids containing proteins and minerals, and increase the absorption of minerals by the human body (e.g., high mineral (e.g. calcium)-containing beverages, minerals (e.g. calcium) absorption enhancer manufacturing use); use to reduce bitterness, use to improve protease proteolytic rate, and/or use to enhance glutamic acid content (e.g., amino acid seasoning (animal protein hydrolyzate (HAP), hydrolyzate of vegetable protein (HVP)), production of miso and soy sauce), and the like.
- HAP animal protein hydrolyzate
- HVP hydrolyzate of vegetable protein
- guanidinium compounds and/or polyamines can improve the thermal stability of protein deamidase.
- coexistence of a guanidinium compound and/or polyamine allows the enzyme to act in a stable state.
- (P) protein (hereinafter also referred to as "(P) component") is treated with (A) protein deamidase in the presence of (B) a guanidinium compound and/or polyamine. Also provided is a method for deamidating a protein, comprising the step of allowing the deamidation reaction to proceed.
- the protein deamidation method of the present invention can be used to produce deamidated proteins. Therefore, according to the present invention, a reaction mixture containing (P) protein, (A) protein deamidase, and (B) a guanidium compound and/or polyamine proceeds with the deamidation reaction of component (P).
- a method for producing a deamidated protein is also provided, comprising the step of allowing. Furthermore, the method for producing a deamidated protein of the present invention can be used for producing food, beverages or pharmaceuticals.
- the present invention provides a reaction mixture containing (P) a protein-containing raw material for food or drink or a pharmaceutical raw material, (A) protein deamidase, and (B) a guanidium compound and/or polyamine, wherein (P)
- the present invention also provides a method for producing food, drink or pharmaceuticals, including the step of allowing the deamidation reaction of the ingredients to proceed.
- the method for deamidating a protein of the present invention and the method for producing a deamidated protein are collectively referred to as "the method of the present invention”.
- the protein which is the component (P) to be deamidated in the method of the present invention, may be either vegetable protein or animal protein. In the method and production method of the present invention, either vegetable protein or animal protein may be used as the (P) component, or both may be used in combination.
- the reaction mixture can be prepared by using the enzyme preparation described in the above "1. Enzyme preparation" and mixing the enzyme preparation with the component (P). can.
- Enzyme preparation and mixing the enzyme preparation with the component (P).
- the component (A) contained in the enzyme preparation has excellent thermal stability, the activity of the component (A) can be efficiently enjoyed.
- the activity of the component (A) can be exhibited stably even under the heating conditions used in the step of advancing the deamidation reaction.
- the reaction mixture can be prepared by mixing the (A) component with the mixture containing the (P) component and the (B) component.
- the activity of the component (A) can be exhibited stably under the heating conditions used in the step of advancing the deamidation reaction.
- the amount of component (A) used relative to component (P) can be the amount used in known methods without any particular limitation. Also, the ratio of the amount of component (A) and component (B) used may be appropriately set according to the desired degree of thermal stability improvement effect of component (A).
- the amount of component (B) used per 1U of component (A) is, for example, 0.5 ⁇ mol or more. More preferably 4 ⁇ mol or more, and still more preferably 9 ⁇ mol or more.
- the upper limit of the amount of component (B) to be used per 1U of component (A) is not particularly limited, but is, for example, 50 ⁇ mol or less, preferably 30 ⁇ mol or less, more preferably 15 ⁇ mol or less.
- reaction conditions temperature, time, pH, etc.
- Optimum treatment conditions may be determined through preliminary experiments.
- the temperature conditions in the step of proceeding with the deamidation reaction can be appropriately set according to the optimum temperature of the component (A).
- the temperature conditions may be set to a temperature higher than the optimum temperature for the component (A).
- the temperature condition a temperature at which the component (A) is deactivated when the component (B) is not coexistent is acceptable.
- the temperature conditions are, for example, 5 to 15° C., preferably 8 to 12° C. higher than the optimum temperature of component (A).
- the method, etc. of the present invention can include steps other than the step of proceeding with the deamidation reaction.
- the other steps are not particularly limited as long as they are suitable for the uses described in "1-5. Applications", and include, for example, an enzyme deactivation step, a cooling step, a filtration step, a cooking step, and the like. These other steps may be performed singly or in combination of two or more steps.
- Protein deamidase Chryseobacterium proteolyticum-derived protein glutaminase (manufactured by Amano Enzyme) was used as the protein deamidase. This protein glutaminase has an optimum temperature of 60°C and is inactivated by treatment at 70°C for 1 hour. In the following, this protein deamidase is also referred to as "PG".
- the protein deamidase activity value was measured by the following method. 0.1 mL of sample solution containing protein deamidase was added to 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly, left at 37° C. for 10 minutes, and then treated with 0.4 M TCA. 1 mL of solution was added to stop the reaction. As a blank, 1 mL of 0.4 M TCA solution was added to 1 mL of 0.2 M phosphate buffer (pH 6.5) containing 30 mM Z-Gln-Gly, and 0.1 mL of sample solution containing protein deamidase was added, It was left at 37°C for 10 minutes.
- the amount of ammonia generated in the reaction solution was measured using Ammonia Test Wako (Fujifilm Wako Pure Chemical Industries, Ltd.).
- the ammonia concentration in the reaction solution was obtained from a calibration curve representing the relationship between ammonia concentration and absorbance (630 nm) prepared using an ammonia standard solution (ammonium chloride).
- the activity of protein deamidase was calculated from the following formula, with the amount of enzyme that generates 1 ⁇ mol of ammonia per minute as 1 unit (1 U).
- the reaction liquid volume is 2.1
- the enzyme solution volume is 0.1
- Df is the dilution ratio of the enzyme solution.
- 17.03 is the molecular weight of ammonia.
- Enzyme solutions containing component (A) (PG) at a final concentration of 100 U/mL with or without component (B) were prepared.
- the pH of the prepared enzyme solution at 25°C was adjusted to 7.0.
- the enzyme solution was subjected to heat treatment at 70° C. for a predetermined time, and the degree of thermal aggregation of the enzyme was evaluated by measuring the absorbance at 413 nm. A higher absorbance indicates a higher extent to which the enzyme forms thermal aggregates, ie, a lower thermal stability.
- Test Example 1 0.5 M of various amino acids were added to PG (final concentration: 100 U/mL) as component (A) to prepare an enzyme solution having a pH of 7.0 at 25°C. Separately, an enzyme solution (control; Ctrl) was prepared in the same manner except that no amino acid was added. Each enzyme solution was heat-treated at 70° C. for 15 minutes, then rapidly cooled to room temperature and the absorbance at 413 nm was measured. The results for each enzyme solution are shown in FIG.
- the arginine-added groups (0.1 M Arg, 0.5 M Arg, and 1.0 M Arg) depended on the added arginine concentration. A decrease in absorbance value was confirmed. In other words, it was found from these results that arginine, which is the component (B), improves the thermal stability of PG.
- Example 3 0.1 M of component (B) (arginine, argininamide, or spermidine) was added to component (A), PG (final concentration: 100 U/mL), and the solution was adjusted to pH 7.0 at 25°C. was prepared. Separately, an enzyme solution (control; Ctrl) was prepared in the same manner except that component (B) was not added. Each prepared solution was heat-treated at 60° C. for 10 minutes and the absorbance at 413 nm was measured. The results are shown in FIG.
- the results show that the stability of PG was remarkably improved when using any of arginine, argininamide, and spermidine.
- the absorbance value of the control is 100%
- the relative absorbance of the 0.1M arginine-added section is 70%
- the relative absorbance of the 0.1M arginine amide-added section is 62%
- the relative absorbance of the 0.1M spermidine-added section is 70%.
- Relative absorbance was 45%. In other words, the effect of improving the thermal stability of PG by spermidine was remarkable.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Le but de la présente invention est de fournir un agent sous forme de protéine désamidase présentant une stabilité thermique améliorée. Un composé guanidinium et une polyamine peuvent améliorer la stabilité thermique d'une protéine désamidase.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022015917 | 2022-02-03 | ||
JP2022-015917 | 2022-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023149512A1 true WO2023149512A1 (fr) | 2023-08-10 |
Family
ID=87552552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2023/003428 WO2023149512A1 (fr) | 2022-02-03 | 2023-02-02 | Préparation enzymatique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2023149512A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012060409A1 (fr) * | 2010-11-05 | 2012-05-10 | 味の素株式会社 | Procédé de fabrication de viandes transformées, et préparation d'enzymes pour l'amélioration de viandes transformées |
WO2013012022A1 (fr) * | 2011-07-19 | 2013-01-24 | 中外製薬株式会社 | Préparation à teneur en protéines stable renfermant de l'argininamide ou un composé analogue correspondant |
WO2015064591A1 (fr) * | 2013-10-28 | 2015-05-07 | テルモ株式会社 | Suspension aqueuse de protéine |
JP2021520815A (ja) * | 2018-04-10 | 2021-08-26 | グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. | T7rnaポリメラーゼバリアント |
WO2021201277A1 (fr) * | 2020-04-03 | 2021-10-07 | 天野エンザイム株式会社 | Procédé de désamidation d'une protéine |
-
2023
- 2023-02-02 WO PCT/JP2023/003428 patent/WO2023149512A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012060409A1 (fr) * | 2010-11-05 | 2012-05-10 | 味の素株式会社 | Procédé de fabrication de viandes transformées, et préparation d'enzymes pour l'amélioration de viandes transformées |
WO2013012022A1 (fr) * | 2011-07-19 | 2013-01-24 | 中外製薬株式会社 | Préparation à teneur en protéines stable renfermant de l'argininamide ou un composé analogue correspondant |
WO2015064591A1 (fr) * | 2013-10-28 | 2015-05-07 | テルモ株式会社 | Suspension aqueuse de protéine |
JP2021520815A (ja) * | 2018-04-10 | 2021-08-26 | グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. | T7rnaポリメラーゼバリアント |
WO2021201277A1 (fr) * | 2020-04-03 | 2021-10-07 | 天野エンザイム株式会社 | Procédé de désamidation d'une protéine |
Non-Patent Citations (1)
Title |
---|
KOVACEVIC Z, DAY S H, COLLETT V, BROSNAN J T, BROSNAN M E: "Activation of hepatic glutaminase by spermine", BIOCHEMICAL JOURNAL, PUBLISHED BY PORTLAND PRESS ON BEHALF OF THE BIOCHEMICAL SOCIETY., GB, vol. 305, no. 3, 1 February 1995 (1995-02-01), GB , pages 837 - 841, XP093083350, ISSN: 0264-6021, DOI: 10.1042/bj3050837 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022244875A1 (fr) | Procédé de production d'aliment, de boisson ou de matière alimentaire à base d'avoine | |
JP5497984B2 (ja) | ビール又はビール様飲料の製造方法 | |
WO2022102723A1 (fr) | Procédé de production d'une composition liquide contenant une protéine traitée dérivée d'une plante | |
US11685914B2 (en) | Stabilised dry protein deamidase composition | |
CN116916759A (zh) | 含有加工大麻蛋白质的液态组合物的制造方法 | |
JP3961956B2 (ja) | 乳蛋白質の脱アミド化方法及び乳蛋白質の変性方法 | |
WO2022071418A1 (fr) | Procédé de production de lait végétal traité | |
WO2022191303A1 (fr) | Procédé de production de produit de dégradation de protéine et préparation enzymatique | |
WO2014171359A1 (fr) | Produit de dégradation de gluten de blé | |
CN107400690B (zh) | 大米蛋白制备方法 | |
CN101717763A (zh) | 一种提高液体氨肽酶稳定性的方法及该酶的应用 | |
EP4238421A1 (fr) | Procédé de fabrication de produit transformé aux protéines végétales dont la texture est améliorée | |
JP5421117B2 (ja) | イースト抽出物を製造する方法 | |
US20230404097A1 (en) | Method for manufacturing processed article of plant protein food/beverage product in which aroma is enhanced | |
WO2023149512A1 (fr) | Préparation enzymatique | |
WO2022118914A1 (fr) | Préparation enzymatique liquide | |
WO2024053745A1 (fr) | Procédé de production d'une composition traitée contenant des protéines végétales | |
WO2024257876A1 (fr) | Préparation enzymatique liquide | |
CN102994477B (zh) | 修饰的米曲霉乳糖酶及其制备方法和应用 | |
WO2024150831A1 (fr) | Procédé de production d'une composition liquide contenant des protéines d'avoine traitées | |
WO2023228953A1 (fr) | Préparation enzymatique liquide | |
JP3639820B2 (ja) | 一定品質のペプチド混合物の製造方法 | |
JP2003339326A (ja) | 乳清蛋白質加水分解物及びその製造方法 | |
JPS62278960A (ja) | 調味料の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23749828 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 23749828 Country of ref document: EP Kind code of ref document: A1 |